Influence of industry on renal guideline development commentary: keeping our eye on the ball and improving chronic kidney disease patient outcomes.
Nissenson
Allen R
AR
Department of Medicine, Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. anissenson@mednet.ucla.edu
D016265:Conflict of Interest; D004345:Drug Industry / Q000592:standards*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*; D017410:Practice Guidelines as Topic / Q000592:standards*; D016896:Treatment Outcome